Compounds > suberoyl bis-hydroxamic acid
Page last updated: 2024-11-04

suberoyl bis-hydroxamic acid and Malignant Melanoma

suberoyl bis-hydroxamic acid has been researched along with Malignant Melanoma in 3 studies

suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, XD3
Gillespie, SK1
Borrow, JM1
Hersey, P3
Wu, JJ1
Gillespie, S2
Borrow, J2

Other Studies

3 other studies available for suberoyl bis-hydroxamic acid and Malignant Melanoma

ArticleYear
The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagoni

2004
Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-15, Volume: 12, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspase 3; Caspa

2006
Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
    Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:12

    Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associat

2006